Clinical Trial Update: Gastrointestinal Tolerability Study Of Dimethyl Fumarate In Participants With Relapsing-Remitting Multiple Sclerosis In Germany [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update reporting results on the gastrointestinal tolerability of dimethyl fumarate in participants with Relapsing-Remitting multiple scle…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Dimethyl fumarate (Dimethyl fumarate)

Snippet

Sponsor: Biogen | Conditions: Relapsing-Remitting Multiple Sclerosis | Phase 4 | Status: COMPLETED | Results posted: 2017-04-18